Catalyst, DyDo Strike Deal to Develop, Market Firdapse in Japan

Catalyst, DyDo Strike Deal to Develop, Market Firdapse in Japan

Lambert-Eaton News

Lambert-Eaton News Today’s multimedia associate, Price Wooldridge, discusses a deal struck by Catalyst Pharmaceuticals and DyDo Pharma to develop and commercialize Firdapse (amifampridine) in Japan for the treatment of L…

Related tracks

See all